CASTLE BIOSCIENCES INC
Company Information
Industry Services-Medical Laboratories
SIC Code 8071
Entity Type operating
SEC Category Accelerated filer
State of Incorporation DE
Business Address 1500 W. PARKWOOD AVE., FRIENDSWOOD, TX, 77546
Mailing Address 1500 W. PARKWOOD AVE., FRIENDSWOOD, TX, 77546
Phone 866-788-9007
Fiscal Year End 1231
EIN 770701774
Financial Overview
FY2024
$455.83M
Stockholders' Equity
$0.66
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 4 Insider stock transaction report | February 5, 2026 | View on SEC |
| 4 Insider stock transaction report | January 22, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | January 21, 2026 | View on SEC |
| 4 Insider stock transaction report | January 14, 2026 | View on SEC |
| 4 Insider stock transaction report | January 14, 2026 | View on SEC |
| 4 Insider stock transaction report | January 14, 2026 | View on SEC |
| 4 Insider stock transaction report | January 14, 2026 | View on SEC |
| 8-K Current report of material events | January 13, 2026 | View on SEC |
| 4 Insider stock transaction report | January 7, 2026 | View on SEC |
| 4 Insider stock transaction report | December 29, 2025 | View on SEC |
Material Events
8-K Other January 13, 2026
High Impact
- Preliminary 2025 revenue expected to be over $340 million, exceeding previous guidance of $327-335 million.
- Core test reports (DecisionDx-Melanoma and TissueCypher) increased by a significant 37% in 2025 compared to 2024.
Insider Trading
STRONG SELL 4 insiders
20 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 8071)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.